AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36089442 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g of force
Number of subjects: 0
Study 36089442 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 g of force
Number of subjects: 0
Study 36089442 — intervention group
Group type: COMPARATOR
Intervention: 50 g or 150 g of force
Number of subjects: 0
Study 32173640 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin combined with exercise training
Number of subjects: 180
Study 32173640 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy (Control)
Number of subjects: 180
Study 35405603 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic kefir (180 mL/d)
Number of subjects: 62
Study 35405603 — intervention group
Group type: COMPARATOR
Intervention: Unfermented milk
Number of subjects: 62
Study 35405603 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic kefir
Number of subjects: 62
Study 35405603 — intervention group
Group type: COMPARATOR
Intervention: Probiotic kefir and unfermented milk
Number of subjects: 62
Study 32621587 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone treatment regimens (three or four times daily)
Number of subjects: 24
Study 35803621 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake prone positioning plus usual care
Number of subjects: 0
Study 35803621 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study 32152811 — intervention group
Group type: EXPERIMENTAL
Intervention: Tagging
Number of subjects: 20
Study 32152811 — intervention group
Group type: EXPERIMENTAL
Intervention: Feature Tracking (FT)
Number of subjects: 20
Study 32152811 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue Tracking (TT)
Number of subjects: 20
Study 34269632 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions designed to enhance treatment engagement
Number of subjects: 52
Study 34011110 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete social and family support
Number of subjects: 70
Study 34011110 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment only (Control)
Number of subjects: 70
Study 32749491 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/d of cholecalciferol)
Number of subjects: 18353
Study 32749491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18353
Study 33579690 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprotumumab
Number of subjects: 171
Study 33579690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 34033171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulforaphane
Number of subjects: 66
Study 34033171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 35428817 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (MID)
Number of subjects: 12
Study 35428817 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 12
Study 35428817 — intervention group
Group type: COMPARATOR
Intervention: Both MID and DEX
Number of subjects: 12
Study 32458091 — intervention group
Group type: EXPERIMENTAL
Intervention: EF training
Number of subjects: 85
Study 32458091 — intervention group
Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 85
Study 32458091 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 85
Study 32149378 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual skills training program
Number of subjects: 70
Study 36013490 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal orthopedic brace, acute use 24 h/day (n = 22)
Number of subjects: 45
Study 36013490 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal orthopedic brace, acute use between 15-18 h/day with specific rehabilitation exercise protocol for six months (n = 23)
Number of subjects: 45
Study 616497335 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention on the basis of conventional nursing care for 4 weeks
Number of subjects: 80
Study 616497335 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing care
Number of subjects: 80
Study 35080497 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-first group (4 weeks of PA followed by 4 weeks of FVC intervention)
Number of subjects: 552
Study 35080497 — intervention group
Group type: EXPERIMENTAL
Intervention: FVC-first group (4 weeks of FVC followed by 4 weeks of PA intervention)
Number of subjects: 552
Study 35080497 — intervention group
Group type: COMPARATOR
Intervention: Control group (8 weeks of placebo treatment unrelated to PA and FVC)
Number of subjects: 552
Study 35080497 — intervention group
Group type: EXPERIMENTAL
Intervention: FVC-first group
Number of subjects: 552
Study 32159187 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant starch enriched cookies (16 g of RS per day)
Number of subjects: 26
Study 32159187 — intervention group
Group type: COMPARATOR
Intervention: Placebo cookies
Number of subjects: 26
Study 34670725 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld ultrasound device
Number of subjects: 40
Study 34670725 — intervention group
Group type: COMPARATOR
Intervention: Traditional palpation
Number of subjects: 40
Study 34391303 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 30
Study 34391303 — intervention group
Group type: COMPARATOR
Intervention: Conventional training (CT)
Number of subjects: 30
Study 32107275 — intervention group
Group type: EXPERIMENTAL
Intervention: iRECIST
Number of subjects: 4751
Study 32107275 — intervention group
Group type: COMPARATOR
Intervention: RECIST V.1.1
Number of subjects: 4751
Study 32107275 — intervention group
Group type: EXPERIMENTAL
Intervention: iPFS
Number of subjects: 4751
Study 32107275 — intervention group
Group type: EXPERIMENTAL
Intervention: PFS
Number of subjects: 4751
Study 35428296 — intervention group
Group type: COMPARATOR
Intervention: Control group of the cluster randomised trial
Number of subjects: 301
Study 32751204 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV-guided training (HRV-G)
Number of subjects: 0
Study 32751204 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (TRAD-G)
Number of subjects: 0
Study 36297014 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAAs (0.17 g/kg BCAAs + 0.17 g/kg glucose)
Number of subjects: 0
Study 36297014 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.34 g/kg glucose)
Number of subjects: 0
Study 34714820 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV, MVA-BN-Filo vaccination at 28-day interval
Number of subjects: 810
Study 34714820 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV, MVA-BN-Filo vaccination at 56-day interval
Number of subjects: 810
Study 34714820 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV, MVA-BN-Filo vaccination at 84-day interval
Number of subjects: 810
Study 34714820 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV booster vaccination after 1 year
Number of subjects: 810
Study 34714820 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 810
Study 34714820 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV, MVA-BN-Filo vaccination in HIV-infected adults at 28-day interval
Number of subjects: 810
Study 34714820 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV, MVA-BN-Filo vaccination in HIV-infected adults at 56-day interval
Number of subjects: 810
Study 35753286 — intervention group
Group type: EXPERIMENTAL
Intervention: Handout + video condition (8-module video intervention and detailed handout)
Number of subjects: 156
Study 35753286 — intervention group
Group type: COMPARATOR
Intervention: Handout condition (detailed handout only)
Number of subjects: 156
Study 33196833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol administration
Number of subjects: 60
Study 33196833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35624201 — intervention group
Group type: EXPERIMENTAL
Intervention: M1 tDCS
Number of subjects: 16
Study 35624201 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar tDCS
Number of subjects: 16
Study 35624201 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16
Study 34447267 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib oral solution (120 mg, 4.8 mL)
Number of subjects: 631
Study 34447267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study 35671039 — intervention group
Group type: EXPERIMENTAL
Intervention: Efpeglenatide 2 mg
Number of subjects: 0
Study 35671039 — intervention group
Group type: EXPERIMENTAL
Intervention: Efpeglenatide 4 mg
Number of subjects: 0
Study 35671039 — intervention group
Group type: EXPERIMENTAL
Intervention: Efpeglenatide 6 mg
Number of subjects: 0
Study 35671039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32816151 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 107847
Study 32816151 — intervention group
Group type: COMPARATOR
Intervention: Oral bisphosphonates
Number of subjects: 107847
Study 35679357 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamlanivimab
Number of subjects: 135
Study 35679357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 33127408 — intervention group
Group type: EXPERIMENTAL
Intervention: VATS left upper lobectomy
Number of subjects: 30
Study 32891292 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy integrated with family recollection (15 minutes, twice a day for 6 days)
Number of subjects: 60
Study 32891292 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 60
Study 35723002 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan at $10/month
Number of subjects: 1013
Study 35723002 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan at $50/month
Number of subjects: 1013
Study 35723002 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan at $100/month
Number of subjects: 1013
Study 35723002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-primed group
Number of subjects: 1013
Study 35723002 — intervention group
Group type: COMPARATOR
Intervention: Not cost-primed group
Number of subjects: 1013
Study 33214331 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 372
Study 33214331 — intervention group
Group type: COMPARATOR
Intervention: NCPAP/NIPPV
Number of subjects: 372
Study 33544989 — intervention group
Group type: EXPERIMENTAL
Intervention: 38%‐SDF + potassium iodide (KI)
Number of subjects: 40
Study 33544989 — intervention group
Group type: EXPERIMENTAL
Intervention: 30%‐SDF
Number of subjects: 40
Study 33544989 — intervention group
Group type: COMPARATOR
Intervention: 2%‐CHX
Number of subjects: 40
Study 33544989 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 33265920 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 16
Study 33265920 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 16
Study 33265920 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (750 mg/m2 intravenously)
Number of subjects: 16
Study 33265920 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (1600 mg per day orally)
Number of subjects: 16
Study 33265920 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (250 mg/m2 per day intravenously)
Number of subjects: 16
Study 36115256 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin analogue therapy (SSA)
Number of subjects: 68
Study 33630460 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to art
Number of subjects: 80
Study 33630460 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 80
Study 32521876 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: 13x3 Gy hypofractionated radiotherapy
Number of subjects: 29
Study 32521876 — intervention group
Group type: COMPARATOR
Intervention: Group B: 2x8.5 Gy and one fraction of 6 Gy hypofractionated radiotherapy
Number of subjects: 29
Study 35015806 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein yogurt (10 g protein/100 g)
Number of subjects: 200
Study 35015806 — intervention group
Group type: COMPARATOR
Intervention: Normal-protein yogurt (3.5 g protein/100 g)
Number of subjects: 200
Study 35015806 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20 µg/d)
Number of subjects: 200
Study 35015806 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no vitamin D)
Number of subjects: 200
Study 35015806 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 200
Study 35015806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 35015806 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein yogurt
Number of subjects: 200
Study 35015806 — intervention group
Group type: COMPARATOR
Intervention: Normal-protein yogurt
Number of subjects: 200
Study 35015806 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein yogurt and vitamin D
Number of subjects: 200
Study 35015806 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-protein yogurt and vitamin D
Number of subjects: 200
Study 33500291 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video on endoscopic extraperitoneal hernia repair
Number of subjects: 0
Study 33500291 — intervention group
Group type: COMPARATOR
Intervention: Mock video
Number of subjects: 0
Study 33500291 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital version of informed consent brochure
Number of subjects: 0
Study 33368338 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose valaciclovir (900 mg, three times daily for 10 days)
Number of subjects: 214
Study 33368338 — intervention group
Group type: COMPARATOR
Intervention: Low-dose valaciclovir (300 mg, two times daily for 10 days)
Number of subjects: 214
Study 33368338 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose valaciclovir
Number of subjects: 214
Study 32419473 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib treatment for patients weighing <60 kg
Number of subjects: 0
Study 32419473 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib treatment for patients weighing ≥60 kg
Number of subjects: 0
Study 32419473 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib treatment
Number of subjects: 0
Study 35833069 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized pelvic floor muscle training (PFMT) with transperineal ultrasound (TPUS) biofeedback
Number of subjects: 77
Study 35833069 — intervention group
Group type: COMPARATOR
Intervention: Individualized pelvic floor muscle training (PFMT) without TPUS biofeedback (control group)
Number of subjects: 77
Study 32586349 — intervention group
Group type: EXPERIMENTAL
Intervention: Core outcome sets (COS) for research and routine care
Number of subjects: 0
Study 32586349 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of COS in electronic health records (EHR)
Number of subjects: 0
Study 32586349 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient‐centred outcomes
Number of subjects: 0
Study 35212278 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuo acupuncture treatment plus lifestyle interventions
Number of subjects: 60
Study 35212278 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving prediabetes health education for lifestyle interventions
Number of subjects: 60
Study 35432836 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive psychological nursing intervention
Number of subjects: 134
Study 35432836 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 134
Study 33486596 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced 2016‐AAO dose (2–3 mg/kg/day)
Number of subjects: 73
Study 33486596 — intervention group
Group type: COMPARATOR
Intervention: Full 2016‐AAO dose (5 mg/kg/day)
Number of subjects: 73
Study 35440667 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil plus bevacizumab (TT‐B)
Number of subjects: 153
Study 35440667 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine plus bevacizumab (C‐B)
Number of subjects: 153
Study 33653121 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg over 40 minutes)
Number of subjects: 17
Study 33653121 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.045 mg/kg over 40 minutes)
Number of subjects: 17
Study 33653121 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 17
Study 33653121 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 17
Study 35450945 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaia COPD app
Number of subjects: 60
Study 35450945 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34060462 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-day post-operative course of oral antibiotics
Number of subjects: 0
Study 34060462 — intervention group
Group type: COMPARATOR
Intervention: Three-day post-operative course of intravenous antibiotics
Number of subjects: 0
Study 34931477 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group
Number of subjects: 80
Study 34931477 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 35841082 — intervention group
Group type: EXPERIMENTAL
Intervention: Men in Mind training (self-paced online training program)
Number of subjects: 0
Study 35841082 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 32629091 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag-mask ventilation (BMV)
Number of subjects: 409
Study 32629091 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation (ETI)
Number of subjects: 409
Study 35063943 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab in combination with frontline carboplatin and paclitaxel chemotherapy
Number of subjects: 0
Study 32338110 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 50
Study 32338110 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 50
Study 33478885 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring Outcome Score (HaOS)
Number of subjects: 400
Study 34160673 — intervention group
Group type: EXPERIMENTAL
Intervention: Headless compression screw (HCS)
Number of subjects: 60
Study 34160673 — intervention group
Group type: COMPARATOR
Intervention: Tension band wire (TBW)
Number of subjects: 60
Study 34510176 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein ingestion (40g) during hemodialysis (PRO)
Number of subjects: 10
Study 34510176 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein ingestion with exercise (PRO+EX)
Number of subjects: 10
Study 34510176 — intervention group
Group type: COMPARATOR
Intervention: Placebo ingestion during hemodialysis (PLA)
Number of subjects: 10
Study 34510176 — intervention group
Group type: COMPARATOR
Intervention: Placebo ingestion with exercise (PLA+EX)
Number of subjects: 10
Study 34510176 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein ingestion (PRO)
Number of subjects: 10
Study 34510176 — intervention group
Group type: COMPARATOR
Intervention: Placebo ingestion (PLA)
Number of subjects: 10
Study 35183671 — intervention group
Group type: EXPERIMENTAL
Intervention: True air filtration
Number of subjects: 54
Study 35183671 — intervention group
Group type: COMPARATOR
Intervention: Sham air filtration
Number of subjects: 54
Study 35183671 — intervention group
Group type: EXPERIMENTAL
Intervention: PM2.5 exposure increase
Number of subjects: 54
Study 35183671 — intervention group
Group type: EXPERIMENTAL
Intervention: PM2.5 exposure
Number of subjects: 54
Study 34143258 — intervention group
Group type: EXPERIMENTAL
Intervention: LV‐RBP (52.5 g of PMF104 in 500 mL of water)
Number of subjects: 110
Study 34143258 — intervention group
Group type: COMPARATOR
Intervention: FV‐RBP (105 g of PMF104 in 1000 mL of water)
Number of subjects: 110
Study 34143258 — intervention group
Group type: EXPERIMENTAL
Intervention: LV‐RBP
Number of subjects: 110
Study 34143258 — intervention group
Group type: COMPARATOR
Intervention: FV‐RBP
Number of subjects: 110
Study 32423422 — intervention group
Group type: EXPERIMENTAL
Intervention: Local solutions implemented to strengthen LTBI management
Number of subjects: 125
Study 35503773 — intervention group
Group type: EXPERIMENTAL
Intervention: Group antenatal care (G-ANC)
Number of subjects: 20
Study 34689837 — intervention group
Group type: EXPERIMENTAL
Intervention: RGw-mHealth (LLRP + IDC + mHealth)
Number of subjects: 114
Study 34689837 — intervention group
Group type: EXPERIMENTAL
Intervention: RGwo-mHealth (LLRP + IDC)
Number of subjects: 114
Study 34689837 — intervention group
Group type: COMPARATOR
Intervention: CG (IDC)
Number of subjects: 114
Study 34689837 — intervention group
Group type: EXPERIMENTAL
Intervention: RGw-mHealth
Number of subjects: 114
Study 34689837 — intervention group
Group type: EXPERIMENTAL
Intervention: RGwo-mHealth
Number of subjects: 114
Study 34689837 — intervention group
Group type: COMPARATOR
Intervention: CG
Number of subjects: 114
Study 35755843 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model
Number of subjects: 648
Study 35755843 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) model
Number of subjects: 648
Study 35755843 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 648
Study 33593307 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy (OT) specialist consultation
Number of subjects: 400
Study 33593307 — intervention group
Group type: COMPARATOR
Intervention: Rheumatologist consultation
Number of subjects: 400
Study 33782959 — intervention group
Group type: EXPERIMENTAL
Intervention: TA (4 mg/mL) intradermal injections every 2 weeks
Number of subjects: 60
Study 33782959 — intervention group
Group type: EXPERIMENTAL
Intervention: TA (10 mg/mL) intradermal injections every 2 weeks
Number of subjects: 60
Study 33782959 — intervention group
Group type: COMPARATOR
Intervention: Topical TA cream (10% concentration) twice daily
Number of subjects: 60
Study 33051867 — intervention group
Group type: EXPERIMENTAL
Intervention: START‐Play intervention
Number of subjects: 103
Study 33051867 — intervention group
Group type: COMPARATOR
Intervention: usual early intervention (uEI) services
Number of subjects: 103
Study 36113023 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber, high-fruit and vegetable, and low-fat dietary intervention
Number of subjects: 368
Study 36113023 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 368